|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 08, 2018 12:43AM
|
|
Re: Down 53% today
|
2
|
Zenith Epigenetics
|
Jun 08, 2023 10:52AM
|
|
Re: Games being played on the share price
|
2
|
Resverlogix Corp.
|
May 02, 2019 06:15PM
|
|
Re: Review of ZCC history
|
2
|
Zenith Epigenetics
|
Aug 29, 2023 10:37AM
|
|
Re: Long Covid
|
2
|
Resverlogix Corp.
|
Jan 21, 2024 09:16PM
|
|
Re: USA Volume Interesting
|
2
|
Resverlogix Corp.
|
Sep 20, 2016 01:51PM
|
|
Re: Link to 2023 AGM presentation is up
|
2
|
Resverlogix Corp.
|
Jun 21, 2023 01:34PM
|
|
Re: Long covid trials
|
2
|
Resverlogix Corp.
|
Aug 01, 2023 09:53AM
|
|
Re: Allow Me A Small Rant....
|
2
|
Resverlogix Corp.
|
Jan 27, 2017 09:07AM
|
|
Re: Technical Difficulties
|
2
|
Resverlogix Corp.
|
Oct 11, 2017 01:16PM
|
|
Re: On the outside looking in....
|
2
|
Resverlogix Corp.
|
Sep 23, 2017 02:01PM
|
|
Re: ...isn't this interesting...
|
2
|
Resverlogix Corp.
|
Jul 07, 2015 01:04PM
|
|
Re: For The Record
|
2
|
Zenith Epigenetics
|
Sep 28, 2022 07:52AM
|
|
Re: Update
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 10:34AM
|
|
Re: Update
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 10:37AM
|
|
Re: Could it be
|
2
|
Zenith Epigenetics
|
Oct 27, 2023 11:05AM
|
|
Re: $2.00 financing
|
2
|
Resverlogix Corp.
|
Mar 22, 2017 07:39PM
|
|
Re: Additional Reports of Exempt Distribution
|
2
|
Zenith Epigenetics
|
Jul 25, 2023 07:31AM
|
|
Re: Long Covid remains a big challenge
|
2
|
Resverlogix Corp.
|
Jul 25, 2023 07:34AM
|
|
Re: Zenith-Oncology Pipeline
|
2
|
Zenith Epigenetics
|
Mar 22, 2021 04:08PM
|
